{
    "title": "Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach",
    "author": "4 M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Salma Akter, A. S. M",
    "date": 2020,
    "affiliations": [
        "Department of Microbiology, University of Dhaka, Dhaka 1000, Bangladesh"
    ],
    "identifiers": {
        "arxiv": null,
        "doi": "10.1101/2020.03.30.015164",
        "isbn": null,
        "doc_id": null,
        "url": "http://biorxiv.org/cgi/content/short/2020.03.30.015164.pdf"
    },
    "abstract": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing pandemic of coronavirus disease 2019 (COVID-19), a public health emergency of international concern declared by the World Health Organization (WHO). An immunoinformatics approach along with comparative genomic was applied to design a multi-epitopebased peptide vaccine against SARS-CoV-2 combining the antigenic epitopes of the S, M and E",
    "keywords": [
        "SARS-CoV-2",
        "Muti-epitope",
        "Chimeric Peptide Vaccine",
        "B-cell Epitope",
        "T-cell"
    ],
    "funding": [
        {}
    ]
}